Lingenfelser T, Blackshaw L A, Sun W M, Dent J
Royal Adelaide Hospital, South Australia.
Neurogastroenterol Motil. 1997 Sep;9(3):167-75. doi: 10.1046/j.1365-2982.1997.d01-39.x.
This study has investigated the relative importance of central nervous and peripheral nitroxidergic mechanisms in the control of pyloric motility. In 10 urethane-anaesthetized ferrets, drugs were administered directly to the CNS via a 0.5-mm-diameter cannula inserted into the 4th ventricle, approximately at the obex. Drugs were also given directly to the upper GI tract by close intra-arterial (i.a.) injection at the coeliac axis. Antropyloroduodenal pressures were recorded with a five-channel sleeve/sidehole micromanometric assembly (1.35 x 1.75 mm o.d.), which was introduced via the duodenum. Pyloric motility was stimulated throughout the main part of each study with a continuous i.v. infusion of CCK-8 (30 pmol min-1). This infusion produced an immediate and sustained increase in tonic and phasic pyloric activity, and sustained abolition of antral pressure waves. CCK-8 also induced a duodenal motor response, but this was short-lived (11.4 +/- 7.9 min). Coeliac axis injection of the NO donor S-nitroso-N-acetyl-penicillamine (SNAP) decreased phasic pyloric activity (from 330 +/- 35 to 148 +/- 21 mmHg min-1 after SNAP 5 micrograms, P < 0.01). By comparison central SNAP administration over the same dose range had no effect on CCK-stimulated pyloric motlity. Inhibition of endogenous NO synthase with L-Nitro Arginine Methyl Ester (L-NAME, 100 mg kg-1 close i.a.) caused a marked increase of phase pyloric motor activity from 349 +/- 59 to 1044 +/- 140 mmHg min-1 (P < 0.01). In addition, SNAP caused marked stimulation of pyloric tone from 2.6 +/- 0.5 to 13.1 +/- 2.8 mmHg (P < 0.01). Central nervous administration of L-NAME caused modest enhancement of phasic pyloric activity (248 +/- 31 to 283 +/- 32 mmHg min-1 P < 0.05) and pyloric tone (2.6 +/- 0.5 to 3.7 +/- 0.7 mmHg, P < 0.05). Our data indicate that motor activity of the ferret pylorus is potently modulated by NO released within the upper gut. Additionally, there is potential for modulation of pyloric motility by central nervous system production of NO.
本研究调查了中枢神经和外周氮氧化物能机制在控制幽门运动中的相对重要性。在10只经氨基甲酸乙酯麻醉的雪貂中,通过插入第四脑室(约在闩部)的直径为0.5毫米的套管将药物直接注入中枢神经系统。药物还通过在腹腔动脉轴进行紧密的动脉内注射直接给予上消化道。用五通道套管/侧孔微测压组件(外径1.35×1.75毫米)经十二指肠记录胃窦幽门十二指肠压力。在每项研究的主要部分,通过持续静脉输注胆囊收缩素-8(CCK-8,30皮摩尔/分钟)刺激幽门运动。这种输注立即并持续增加了幽门的紧张性和阶段性活动,并持续消除了胃窦压力波。CCK-8还诱导了十二指肠运动反应,但这种反应是短暂的(11.4±7.9分钟)。腹腔动脉轴注射一氧化氮供体S-亚硝基-N-乙酰青霉胺(SNAP)可降低幽门的阶段性活动(SNAP 5微克后从330±35降至148±21毫米汞柱/分钟,P<0.01)。相比之下,在相同剂量范围内中枢给予SNAP对CCK刺激的幽门运动没有影响。用L-硝基精氨酸甲酯(L-NAME,100毫克/千克,紧密动脉内注射)抑制内源性一氧化氮合酶导致幽门阶段性运动活动从349±59显著增加到1044±140毫米汞柱/分钟(P<0.01)。此外,SNAP使幽门张力从2.6±0.5显著增加到13.1±2.8毫米汞柱(P<0.01)。中枢给予L-NAME使幽门阶段性活动适度增强(从248±31到283±32毫米汞柱/分钟,P<0.05),幽门张力增加(从2.6±0.5到3.7±0.7毫米汞柱,P<0.05)。我们的数据表明,雪貂幽门的运动活动受到上消化道内释放的一氧化氮的有效调节。此外,中枢神经系统产生的一氧化氮有可能调节幽门运动。